NASDAQ · BKYI

BIO – key International, Inc.

$4.75 +$0.20 (+4.49%) 1D Pre-market

Key Metrics

$4.93M
Market cap
9.28×
P/E · TTM
Revenue · TTM
$531.51K
Net income
EPS · TTM $1.13
Dividend yield
Free cash flow
Beta · 1Y 0.42
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 7
    The stock moved +43.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 7
  • May 12
    From its Feb 3 high, the share price fell 55%.

    Peak close $7.70 on Feb 3; trough close $3.46 on May 12. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -55%
  • May 12
    The stock moved -34.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.93M
Enterprise value
Shares outstanding1.1M
52-wk range$0.53 – $8.78
Avg volume · 20D1.0M
Net cash
Book value / share$10.40
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About BIO – key International, Inc.
IPO dateFeb 24, 1997
Employees42

BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA).

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E9.28
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$16.27

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 12.3% · —

Financial Health

Current ratio1.41
Quick ratio1.30
Debt / equity
Debt / EBITDA
Net cash
Working capital$1.30M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$16.27 vs $4.75
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings